25 May 2013
Keywords: update, merck, co, emend, gets, backing, fda
Article | 17 March 2003
Merck & Co's new drug for the prevention of nausea and vomiting inpatients undergoing chemotherapy for cancer, Emend (aprepitant), has won
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2003
24 May 2013
© 2013 thepharmaletter.com